- Home
- LION vs BEAM Comparison
LION vs BEAM Comparison
Compare LION & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LION
- BEAM
- Stock Information
- Founded
- LION 1997
- BEAM 2017
- Country
- LION Canada
- BEAM United States
- Employees
- LION N/A
- BEAM N/A
- Industry
- LION Movies/Entertainment
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LION Consumer Discretionary
- BEAM Health Care
- Exchange
- LION Nasdaq
- BEAM Nasdaq
- Market Cap
- LION 2.0B
- BEAM 1.9B
- IPO Year
- LION N/A
- BEAM 2020
- Fundamental
- Price
- LION $7.24
- BEAM $28.73
- Analyst Decision
- LION Strong Buy
- BEAM Buy
- Analyst Count
- LION 3
- BEAM 10
- Target Price
- LION $11.33
- BEAM $47.67
- AVG Volume (30 Days)
- LION 339.1K
- BEAM 1.0M
- Earning Date
- LION 11-07-2024
- BEAM 11-05-2024
- Dividend Yield
- LION N/A
- BEAM N/A
- EPS Growth
- LION N/A
- BEAM N/A
- EPS
- LION N/A
- BEAM N/A
- Revenue
- LION $2,983,500,000.00
- BEAM $349,643,000.00
- Revenue This Year
- LION $6.15
- BEAM N/A
- Revenue Next Year
- LION $8.01
- BEAM $10.82
- P/E Ratio
- LION N/A
- BEAM N/A
- Revenue Growth
- LION N/A
- BEAM 328.73
- 52 Week Low
- LION $6.13
- BEAM $20.84
- 52 Week High
- LION $12.84
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- LION 56.33
- BEAM 56.65
- Support Level
- LION $6.99
- BEAM $27.02
- Resistance Level
- LION $7.49
- BEAM $29.53
- Average True Range (ATR)
- LION 0.29
- BEAM 1.73
- MACD
- LION 0.01
- BEAM 0.10
- Stochastic Oscillator
- LION 57.53
- BEAM 59.63
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.